thiazolidines has been researched along with Diabetic Glomerulosclerosis in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.55) | 18.7374 |
| 1990's | 7 (31.82) | 18.2507 |
| 2000's | 9 (40.91) | 29.6817 |
| 2010's | 5 (22.73) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aa, JY; Ding, F; Gao, HX; He, J; Sun, RB; Wang, GJ; Wang, JK; Xie, Y; Yang, N; Zeng, CH; Zhang, JW; Zhu, XD | 1 |
| Takahashi, H; Yajima, K; Yajima, T; Yasuda, K | 1 |
| Fujii, M; Iida, Y; Kanasaki, K; Kitada, M; Konishi, K; Koya, D; Nakagawa, A; Nitta, K; Ogura, Y | 1 |
| Kanasaki, K; Katoh, M; Kitada, M; Koya, D; Shi, S; Takagaki, Y | 1 |
| Yasuda, H | 1 |
| Ogawa, D; Shikata, K | 1 |
| Kawakami, M; Kuroki, M | 1 |
| Aoyama, I; Enomoto, A; Nakamura, S; Niwa, T; Tachikawa, T; Takayama, F; Tobita, K | 1 |
| Abe, H; Arai, H; Doi, T; Kita, T; Nagata, K; Ohashi, S; Okamoto, H; Takahashi, T; Takeuchi, M; Yamamoto, H; Yamamoto, Y | 1 |
| Hayakawa, N; Itoh, M; Nagasaka, A; Nagata, M; Nakano, I; Oda, N; Sawai, Y; Shinohara, R; Suzuki, A; Takeda, F; Tsugawa, T | 1 |
| Izuhara, Y; Miyata, T; Yamamoto, M | 1 |
| Cooper, ME; Coughlan, MT; Forbes, JM | 1 |
| Ebata, K; Haneda, M; Itagaki, I; Kamanaka, Y; Kikkawa, R; Shigeta, Y; Shimizu, K | 1 |
| Aufricht, C; Hayde, M; Höger, H; Lubec, B; Lubec, G; Mallinger, WR; Rokitansky, A; Wagner, U | 1 |
| Inokuchi, T; Isogai, S; Ohe, K | 1 |
| Fujii, W; Ishikawa, S; Kawata, T; Koike, T; Makita, Z; Nakamura, S; Yanagisawa, K; Yasumura, K | 1 |
| Aono, T; Fujita, T; Hamada, M; Hayakawa, N; Hayashi, R; Itoh, M; Kakizawa, H; Makino, M; Nagasaka, A; Nagata, M; Shinohara, R; Uchimura, K | 1 |
| Atsumi, T; Ishida, M; Ishikawa, S; Koike, T; Makita, Z; Miyoshi, H; Obara, S; Tsuchida, K; Yamagishi, S; Yasumura, K | 1 |
| Doi, T; Kato, I; Ohashi, S; Okamoto, H; Sakurai, S; Takasawa, S; Takeuchi, M; Watanabe, T; Yamagishi, S; Yamamoto, H; Yamamoto, Y; Yonekura, H | 1 |
| Kurokawa, K; Miyata, T; Suzuki, D | 1 |
| Iwamoto, Y | 1 |
| Kador, PF; Kinoshita, JH; Sharpless, NE | 1 |
6 review(s) available for thiazolidines and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
[Pathophysiology and treatment for diabetic neuropathy].
Topics: Aldehyde Reductase; Diabetic Nephropathies; Enzyme Inhibitors; Genetic Therapy; Humans; Hypoglycemic Agents; Imidazolidines; Neuralgia; Neurologic Examination; Regenerative Medicine; Rhodanine; Thiazolidines | 2009 |
[Microinflammation in diabetic nephropathy].
Topics: Animals; Diabetic Nephropathies; Drug Design; Glucagon-Like Peptide 1; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Insulin Resistance; Metabolic Syndrome; Mice; Molecular Targeted Therapy; PPAR gamma; Rats; Thiazolidines | 2011 |
[Aminoguanidine and other AGE inhibitors].
Topics: Amides; Animals; Arteriosclerosis; Cardiovascular Diseases; Cataract; Clinical Trials as Topic; Diabetes Mellitus; Diabetic Nephropathies; Diabetic Retinopathy; Disease Models, Animal; Drug Design; Glycation End Products, Advanced; Guanidines; Humans; Hydrazines; Hypoglycemic Agents; Thiadiazoles; Thiazoles; Thiazolidines | 2002 |
Can advanced glycation end product inhibitors modulate more than one pathway to enhance renoprotection in diabetes?
Topics: Animals; Diabetic Nephropathies; Disease Models, Animal; Glycation End Products, Advanced; Guanidines; Humans; Pyridoxamine; Renin-Angiotensin System; Thiadiazoles; Thiazolidines | 2005 |
Carbonyl stress.
Topics: Diabetic Nephropathies; Glycation End Products, Advanced; Humans; Kidney Glomerulus; Nitriles; Oxidation-Reduction; Oxidative Stress; Thiadiazoles; Thiazolidines | 2001 |
Aldose reductase inhibitors: a potential new class of agents for the pharmacological control of certain diabetic complications.
Topics: Aldehyde Reductase; Animals; Binding Sites; Blood Glucose; Cataract; Chemical Phenomena; Chemistry; Corneal Diseases; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Disease Models, Animal; Fluorenes; Galactose; Humans; Hydantoins; Imidazoles; Imidazolidines; Models, Molecular; Naphthalenes; Phthalazines; Rhodanine; Sorbitol; Structure-Activity Relationship; Substrate Specificity; Sugar Alcohol Dehydrogenases; Thiazolidines; Tissue Distribution | 1985 |
16 other study(ies) available for thiazolidines and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
The aldose reductase inhibitor epalrestat exerts nephritic protection on diabetic nephropathy in db/db mice through metabolic modulation.
Topics: Albuminuria; Aldehyde Reductase; Animals; Diabetic Nephropathies; Enzyme Inhibitors; Fructose; Inositol; Kidney; Male; Metabolomics; Mice; Protective Agents; Rhodanine; Sorbitol; Thiazolidines | 2019 |
The effect of dulaglutide on body composition in type 2 diabetes mellitus patients on hemodialysis.
Topics: Aged; Body Composition; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glucagon-Like Peptides; Humans; Immunoglobulin Fc Fragments; Male; Middle Aged; Pyrazoles; Recombinant Fusion Proteins; Renal Dialysis; Renal Insufficiency, Chronic; Sarcopenia; Thiazolidines | 2018 |
Effect of switching to teneligliptin from other dipeptidyl peptidase-4 inhibitors on glucose control and renoprotection in type 2 diabetes patients with diabetic kidney disease.
Topics: Aged; Biomarkers; Blood Glucose; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dipeptidyl-Peptidase IV Inhibitors; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Hypoglycemia; Incidence; Japan; Male; Prognosis; Prospective Studies; Pyrazoles; Thiazolidines | 2019 |
Dipeptidyl peptidase-4 plays a pathogenic role in BSA-induced kidney injury in diabetic mice.
Topics: Animals; Caveolin 1; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Epithelial-Mesenchymal Transition; Fibrosis; Humans; Integrin beta1; Kidney Tubules; Male; Mice; Pyrazoles; Serum Albumin, Bovine; Signal Transduction; Smad3 Protein; Thiazolidines; Transforming Growth Factor beta | 2019 |
An inhibitor of advanced glycation end product formation reduces N epsilon-(carboxymethyl)lysine accumulation in glomeruli of diabetic rats.
Topics: Age Factors; Animals; Antibodies, Monoclonal; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Models, Animal; Fluorescent Antibody Technique, Indirect; Glomerular Mesangium; Glycation End Products, Advanced; Kidney; Kidney Glomerulus; Lysine; Rats; Rats, Inbred OLETF; Rats, Inbred Strains; Thiadiazoles; Thiazolidines | 2003 |
Advanced glycation end products increase collagen-specific chaperone protein in mouse diabetic nephropathy.
Topics: Animals; Blood Glucose; Blotting, Western; Cells, Cultured; Collagen; Diabetic Nephropathies; DNA-Binding Proteins; Glomerular Mesangium; Glycation End Products, Advanced; Heat-Shock Proteins; HSP47 Heat-Shock Proteins; Insulin; Kidney; Lasers; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microscopy, Fluorescence; Oligonucleotides, Antisense; Polymerase Chain Reaction; Promoter Regions, Genetic; Ribonucleases; RNA, Messenger; RNA, Small Interfering; Smad Proteins; Thiadiazoles; Thiazolidines; Time Factors; Trans-Activators; Transfection; Transforming Growth Factor beta | 2004 |
Alteration of urinary sorbitol excretion in WBN-kob diabetic rats - treatment with an aldose reductase inhibitor.
Topics: Acetylglucosaminidase; Aldehyde Reductase; Animals; Diabetic Nephropathies; Kidney; Male; Models, Animal; Rats; Rats, Wistar; Rhodanine; Sorbitol; Thiazolidines | 2004 |
From molecular footprints of disease to new therapeutic interventions in diabetic nephropathy.
Topics: Animals; Antioxidants; Biomarkers; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Glycation End Products, Advanced; Guanidines; Humans; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Thiadiazoles; Thiazolidines | 2005 |
The effect of an aldose reductase inhibitor (Epalrestat) on diabetic nephropathy in rats.
Topics: Albuminuria; Aldehyde Reductase; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enzyme-Linked Immunosorbent Assay; Glomerular Filtration Rate; Glomerular Mesangium; Kidney; Male; Organ Size; Rats; Rats, Sprague-Dawley; Renal Circulation; Rhodanine; Thiazolidines | 1994 |
Thiaproline reduces glomerular basement membrane thickness and collagen accumulation in the db/db mouse.
Topics: Animals; Antioxidants; Basement Membrane; Blood Glucose; Collagen; Diabetic Nephropathies; Disease Models, Animal; Female; Fructosamine; Hexosamines; Kidney; Kidney Glomerulus; Mice; Mice, Inbred Strains; Organ Size; Solubility; Thiazoles; Thiazolidines | 1994 |
Effect of an aldose reductase inhibitor on glomerular basement membrane anionic sites in streptozotocin-induced diabetic rats.
Topics: Administration, Oral; Albuminuria; Aldehyde Reductase; Animals; Anions; Basement Membrane; Blood Glucose; Blood Pressure; Cohort Studies; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enzyme Inhibitors; Erythrocytes; Kidney Glomerulus; Male; Rats; Rats, Wistar; Rhodanine; Sorbitol; Thiazolidines; Time Factors | 1995 |
Progression of nephropathy in spontaneous diabetic rats is prevented by OPB-9195, a novel inhibitor of advanced glycation.
Topics: Animals; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Models, Animal; Glomerulosclerosis, Focal Segmental; Glycation End Products, Advanced; Male; Rats; Rats, Inbred Strains; Thiadiazoles; Thiazolidines | 1997 |
Changes in erythrocyte sorbitol concentrations measured using an improved assay system in patients with diabetic complications and treated with aldose reductase inhibitor.
Topics: Adolescent; Adult; Aged; Aldehyde Reductase; Blood Glucose; Child; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Enzyme Inhibitors; Erythrocytes; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; Regression Analysis; Reproducibility of Results; Rhodanine; Sorbitol; Spectrophotometry; Thiazolidines | 1998 |
Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195.
Topics: Animals; Blood Glucose; Collagen; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Endothelial Growth Factors; Gene Expression; Glycation End Products, Advanced; Kidney; Kidney Glomerulus; Lymphokines; Male; Rats; Rats, Inbred OLETF; RNA, Messenger; Thiadiazoles; Thiazolidines; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1999 |
Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice.
Topics: Animals; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Disease Models, Animal; Female; Gene Expression Regulation; Glomerular Mesangium; Glycation End Products, Advanced; Kidney; Male; Mice; Mice, Transgenic; Muscle, Smooth, Vascular; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thiadiazoles; Thiazolidines | 2001 |
[Diabetic complication].
Topics: Aldehyde Reductase; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetic Nephropathies; Diabetic Neuropathies; Glycosylation; Humans; Inositol; Proteins; Rhodanine; Sorbitol; Thiazolidines | 1991 |